Join
Live feed
·
INSIDERFilingvia Quantisnow
Heron Therapeutics Inc. logo

Director Cusack Thomas was granted 53,960 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HRTX· Heron Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HRTX (Heron Therapeutics Inc.) and more on Quantisnow.

Director Cusack Thomas was granted 53,960 shares (SEC Form 4) | Quantisnow